SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-003989
Filing Date
2018-04-03
Accepted
2018-04-03 16:07:20
Documents
1
Period of Report
2018-03-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4033018mohr_delmar.html 4  
1 OWNERSHIP DOCUMENT f4033018mohr_delmar.xml 4 3260
  Complete submission text file 0001213900-18-003989.txt   4692
Mailing Address 8300 GREENSBORO DRIVE MCLEAN VA 22102
Business Address
Mohr Erich (Reporting) CIK: 0001298170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 18733393

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations